Published in Scand J Haematol on January 01, 1972
Advances and challenges in hemophilic arthropathy. Semin Hematol (2015) 0.75
Molecular pathology of haemophilia B. EMBO J (1989) 2.74
Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers. Exp Eye Res (1975) 2.14
Long-term results of endoscopic management of postoperative bile duct strictures with increasing numbers of stents. Gastrointest Endosc (2001) 2.13
Thromboembolic disease--critical evaluation of laboratory investigation. Thromb Haemost (1992) 1.93
Fibrinolytic activity of human veins. Lancet (1967) 1.91
Hematogenous infection in total joint replacement. Clin Orthop Relat Res (1979) 1.89
AHF related protein in clinical praxis. Scand J Haematol (1974) 1.78
Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. Acta Chir Scand (1972) 1.74
Synovectomy, a new approach to haemophilic arthropathy. Acta Haematol (1969) 1.64
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Res (1990) 1.64
Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol) (1980) 1.64
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res (1980) 1.59
Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate. Lancet (1990) 1.53
Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand (1975) 1.51
A nascent secretory protein may traverse the ribosome/endoplasmic reticulum translocase complex as an extended chain. J Biol Chem (1996) 1.51
Determination of plasminogen in clots and thrombi. Thromb Diath Haemorrh (1966) 1.48
Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gynecol Scand (1967) 1.48
Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol (1975) 1.47
Haemophilia prophylaxis in Sweden. Acta Paediatr Scand (1976) 1.46
Haemophilia prophylaxis in young patients--a long-term follow-up. J Intern Med (1997) 1.44
Intravascular coagulation and acute renal failure in a child with mycoplasma infection. Acta Med Scand (1971) 1.44
Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes. J Nucl Cardiol (2000) 1.40
[Threatened future of plasma products. Who is responsible?]. Lakartidningen (1996) 1.39
The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology (1998) 1.30
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol (1965) 1.29
Expression of periostin in human breast cancer. J Clin Pathol (2007) 1.28
Regulation of intraocular pressure and pupil size by beta-blockers and epinephrine. Arch Ophthalmol (1980) 1.27
Two genetic variants of von Willebrand's disease. N Engl J Med (1973) 1.25
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). J Clin Invest (1982) 1.23
[Risk of thromboembolism with oral contraceptives]. Lakartidningen (1967) 1.23
The 1.8 A crystal structure of the dimeric peroxisomal 3-ketoacyl-CoA thiolase of Saccharomyces cerevisiae: implications for substrate binding and reaction mechanism. J Mol Biol (1997) 1.22
Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand Suppl (1965) 1.19
Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J (Clin Res Ed) (1985) 1.19
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med (1983) 1.18
Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy (2006) 1.18
Treatment of ocular hypertension with oral beta-adrenergic blocking agents. Acta Ophthalmol (Copenh) (1974) 1.15
Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Ann Oncol (2008) 1.14
Coagulation and fibrinolytic studies during use of gestagens. Acta Obstet Gynecol Scand (1967) 1.14
Catheter material and blood coagulation studies in vitro. Scand J Haematol (1969) 1.13
Fibrinolysis in newborns. Acta Paediatr Scand (1970) 1.12
New aspects of the pathogenesis of thrombo-embolism. Prog Surg (1973) 1.11
Fibrin degradation products and ovarian tumours. Br Med J (1971) 1.08
Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg. Acta Chir Scand (1970) 1.08
Thrombosis and oral contraceptives: possible predisposition. Br Med J (1973) 1.07
Coagulation and fibrinolytic studies during continuous use of low dose gestagen. Acta Endocrinol (Copenh) (1970) 1.07
Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX. Scand J Haematol (1976) 1.06
Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion (1983) 1.06
Histochemistry and assay of plasminogen activator. Rev Eur Etud Clin Biol (1972) 1.06
A histochemical study of the fibrinolytic activity. Cornea, conjunctiva, and lacrimal gland. Arch Ophthalmol (1967) 1.06
"Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms. Acta Chir Scand (1972) 1.05
Binding of delta-1-tetrahydrocannabinol to human plasma proteins. Biochem Pharmacol (1970) 1.05
Value of streptokinase and heparin in treatment of acute deep venous thrombosis. A coded investigation. Acta Chir Scand (1968) 1.04
Genetic variants of von Willebrand's disease. Br Med J (1972) 1.03
Our experience in Sweden with prophylaxis on haemophilia. Bibl Haematol (1970) 1.03
Inhibition of platelet prothrombinase activity by a lupus anticoagulant. Blood (1983) 1.02
Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study. Acta Neurol Scand (1972) 1.02
Thrombosis in the superior mesenteric and portal veins: report of a case treated with thrombectomy. Surgery (1974) 1.02
Coagulation and fibrinolysis in chronic panniculitis. Acta Derm Venereol (1970) 1.02
Factor XIII (fibrin stabilising factor) in Henoch-Schönlein's purpura. Acta Paediatr Scand (1977) 1.02
An HphI-polymorphism in exon 28 of the von Willebrand factor gene, and its frequency among patients with various forms of von Willebrand's disease. Br J Haematol (1991) 1.02
Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A. Scand J Haematol (1974) 1.02
Outflow resistance in the foetal eye. Acta Ophthalmol (Copenh) (1971) 1.01
The role of beta-1-adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation. Pflugers Arch (1980) 1.01
Pregnancy and parturition in a patient with severe Glanzmann's thrombasthenia. Scand J Haematol (1981) 1.01
Serum fibrin-fibrinogen degradation products in acute myocardial infarction. Lancet (1972) 1.00
Diagnostic symptoms of severe and moderate haemophilia A and B. A survey of 140 cases. Acta Paediatr Scand (1990) 1.00
Fibrinolytic activity of human veins in arms and legs. Thromb Diath Haemorrh (1968) 0.99
"Fibrinolytic capacity" in healthy volunteers at different ages as studied by standardized venous occlusion of arms and legs. Acta Med Scand (1972) 0.99
Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems. Scand J Haematol (1970) 0.99
Autologous blood transfusion in revision hip arthroplasty. A prospective, controlled study of 30 patients. Acta Orthop Scand (1992) 0.98
Extracorporeal shock wave lithotripsy of pancreatic stones in chronic pancreatitis: immediate and medium-term results. Gastrointest Endosc (1997) 0.98
Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity. Br J Haematol (1991) 0.98
Two factor IX mutations in the family of an isolated haemophilia B patient: direct carrier diagnosis by amplification mismatch detection (AMD). Hum Genet (1990) 0.98
Coagulation studies in different types of myeloma. Acta Med Scand Suppl (1966) 0.97
Effect of topical atenolol on intraocular pressure. Br J Ophthalmol (1977) 0.97
Diabetic retinopathy and the fibrinolytic system. Diabetes (1975) 0.97
Origin of mutation in sporadic cases of haemophilia-B. Eur J Haematol (1992) 0.96
Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII. Acta Med Scand (1972) 0.96
Occurrence of arteriosclerosis in von Willebrand's disease. Acta Med Scand (1966) 0.96
von Willebrand's disease. Eur J Haematol (1992) 0.96
Recovery from moderate aphasia in the first year poststroke: effect of type of therapy. Arch Phys Med Rehabil (2001) 0.95
Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage. Acta Neurol Scand (1973) 0.95
Effects of concentration and volume on nasal bioavailability and biological response to desmopressin. J Pharm Sci (1988) 0.95
Cancer, F.D.P., and radiotherapy. Br Med J (1972) 0.94
Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies. Proc Natl Acad Sci U S A (1986) 0.94
Urokinase inhibitors in serum in a clinical series. Acta Med Scand (1971) 0.93
Elimination of tritium-labelled cannabinols in the rat with special reference to the development of tests for the identification of cannabis users. Biochem Pharmacol (1969) 0.93